Pharmena develops sales channels and introduces new brands of cosmetics

WSE-listed biotechnology company The Pharmena Group has conducted intensive work on market analysis, development of the product offer, and introduction of new brands to the portfolio in recent quarters. The increase in the Company's sales this year is to be influenced by the implementation of approximately 80 new products on the drugstore and pharmaceutical market and the introduction of products under the brands of contractors.